Aura Biosciences (AURA) vs Electra Therapeutics (ETRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Aura Biosciences is the larger company by market cap ($669.9 million vs $574.9 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AURA | ETRA |
|---|---|---|
| Share price | $6.46 | $9.16 |
| Market cap | $669.93M | $574.95M |
| 1-day change | +4.70% | -6.72% |
| YTD return | +18.53% | — |
| 1-year return | +12.15% | — |
| EPS (TTM) | $-1.75 | $-2.65 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.54 | $15.50 |
| 52-week low | $4.73 | $8.92 |
| Distance from 52-week high | -32.25% | -40.90% |
| Analyst consensus | none | — |
| Avg. price target upside | +156.97% | — |
| Average volume | 740.43K | 948.89K |
| Shares outstanding | 103.70M | 62.77M |
| Employees | 113 | 46 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Aura Biosciences
AURA stock →Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 113 employees
About Electra Therapeutics
ETRA stock →Electra Therapeutics, Inc. is a clinical-stage biotechnology company.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 46 employees
AURA vs ETRA FAQ
Which is bigger, Aura Biosciences or Electra Therapeutics?
Aura Biosciences (AURA) is larger, with a market capitalization of $669.93M compared with $574.95M for Electra Therapeutics (ETRA).
Are Aura Biosciences and Electra Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.